Cat No.
CEI-1110
Description
SNS-314 is a selective and potent pan Aurora kinase inhibitor currently in a dose escalation phase 1 clinical trial for the treatment of patients with advanced solid tumors.
Abbr
SNS-314(AUR)
CAS No.
1057249-41-8
Product_Overview
Aurora kinase inhibitor
Targets
AUR
Chemical Name
1-(3-chlorophenyl)-3-(5-(2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl)thiazol-2-yl)urea
M.Wt
430.93
Purity
> 95%
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL
Storage
4 centigrade
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
